Literature DB >> 19693531

Fibulin-1 and fibrinogen in human atherosclerotic lesions.

W Scott Argraves1, Asashi Tanaka, Elizabeth P Smith, Waleed O Twal, Kelley M Argraves, Daping Fan, Christian C Haudenschild.   

Abstract

Fibulin-1 is a fibrinogen-binding blood protein and a component of many extracellular matrices (ECM) including those of blood vessels. In this study, the deposition patterns of fibulin-1 and fibrinogen were examined in human coronary artery atherosclerotic lesions excised by atherectomy from 20 patients. Fibulin-1 deposition was found to be closely overlapping with fibrinogen located within the atherosclerotic lesions and in regions containing fresh thrombi. Pronounced intracellular fibulin-1 immunostaining was apparent in lesion areas rich in macrophages and foam cells, although THP-1 macrophages and foam cells were found not to express fibulin-1. Strong ECM deposition of fibulin-1 was observed in acellular atheromatous and myxomatous regions. By contrast, fibulin-1 was present at relatively low levels in the ECM associated with smooth muscle cells within and outside of lesions and was not detected in sclerotic regions. These results reveal the pattern of fibulin-1 within human atherosclerotic lesions and highlight the potential for fibulin-1, perhaps derived from the blood and acting in conjunction with fibrinogen, to play a role in the etiology and cardiovascular disease progression, particularly with respect to thrombotic aspects of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19693531     DOI: 10.1007/s00418-009-0628-7

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  29 in total

1.  Studies on the character and staining of fibrin.

Authors:  A C LENDRUM; D S FRASER; W SLIDDERS; R HENDERSON
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

Review 2.  The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation.

Authors:  J Auwerx
Journal:  Experientia       Date:  1991-01-15

3.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  An association between atherosclerosis and venous thrombosis.

Authors:  Paolo Prandoni; Franca Bilora; Antonio Marchiori; Enrico Bernardi; Francesco Petrobelli; Anthonie W A Lensing; Martin H Prins; Antonio Girolami
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

5.  Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.

Authors:  M G Abrignani; G Novo; A Di Girolamo; R Caruso; R Tantillo; A Braschi; G B Braschi; A Strano; S Novo
Journal:  Cardiologia       Date:  1999-12

6.  Fibrin gel induces the migration of smooth muscle cells from rabbit aortic explants.

Authors:  H Nomura; M Naito; A Iguchi; W D Thompson; E B Smith
Journal:  Thromb Haemost       Date:  1999-10       Impact factor: 5.249

7.  Human fibulin-1D: molecular cloning, expression and similarity with S1-5 protein, a new member of the fibulin gene family.

Authors:  H Tran; M Mattei; S Godyna; W S Argraves
Journal:  Matrix Biol       Date:  1997-03       Impact factor: 11.583

8.  The effect of fibrin on cultured vascular endothelial cells.

Authors:  J L Kadish; C E Butterfield; J Folkman
Journal:  Tissue Cell       Date:  1979       Impact factor: 2.466

9.  Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin.

Authors:  K Balbona; H Tran; S Godyna; K C Ingham; D K Strickland; W S Argraves
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

10.  Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.

Authors:  X J Lou; N W Boonmark; F T Horrigan; J L Degen; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  18 in total

1.  A novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunit.

Authors:  Waleed O Twal; Samar M Hammad; Sharon L Guffy; William S Argraves
Journal:  Matrix Biol       Date:  2015-02-03       Impact factor: 11.583

Review 2.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

3.  Subendothelial matrix components influence endothelial cell apoptosis in vitro.

Authors:  Michael Saemisch; Mercedes Balcells; Lisa Riesinger; Markus Nickmann; Shirin Issa Bhaloo; Elazer R Edelman; Heiko Methe
Journal:  Am J Physiol Cell Physiol       Date:  2018-12-19       Impact factor: 4.249

4.  Gene expression changes: five years after creation of elastase-induced aneurysms.

Authors:  Ramanathan Kadirvel; Yong-Hong Ding; Daying Dai; Debra A Lewis; David F Kallmes
Journal:  J Vasc Interv Radiol       Date:  2011-04-08       Impact factor: 3.464

5.  Reactive carbonyl compounds (RCCs) cause aggregation and dysfunction of fibrinogen.

Authors:  Ya-Jie Xu; Min Qiang; Jin-Ling Zhang; Ying Liu; Rong-Qiao He
Journal:  Protein Cell       Date:  2012-07-26       Impact factor: 14.870

6.  Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis.

Authors:  Jade Jaffar; Sofia Unger; Tamera J Corte; Michael Keller; Paul J Wolters; Luca Richeldi; Stefania Cerri; Cecilia M Prêle; Philip M Hansbro; William Scott Argraves; Rema A Oliver; Brian G Oliver; Judith L Black; Janette K Burgess
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

7.  Fibulin-1 purification from human plasma using affinity chromatography on Factor H-Sepharose.

Authors:  Richard G DiScipio; Robert C Liddington; Ingrid U Schraufstatter
Journal:  Protein Expr Purif       Date:  2016-01-28       Impact factor: 1.650

8.  Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.

Authors:  Wei Feng Ma; Chani J Hodonsky; Adam W Turner; Doris Wong; Yipei Song; Jose Verdezoto Mosquera; Alexandra V Ligay; Lotte Slenders; Christina Gancayco; Huize Pan; Nelson B Barrientos; David Mai; Gabriel F Alencar; Katherine Owsiany; Gary K Owens; Muredach P Reilly; Mingyao Li; Gerard Pasterkamp; Michal Mokry; Sander W van der Laan; Bohdan B Khomtchouk; Clint L Miller
Journal:  Atherosclerosis       Date:  2021-11-26       Impact factor: 5.162

9.  Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.

Authors:  Alexandra Scholze; Else-Marie Bladbjerg; Johannes J Sidelmann; Axel C P Diederichsen; Hans Mickley; Mads Nybo; W Scott Argraves; Peter Marckmann; Lars M Rasmussen
Journal:  Cardiovasc Diabetol       Date:  2013-01-07       Impact factor: 9.951

10.  Alternative Splicing of FN (Fibronectin) Regulates the Composition of the Arterial Wall Under Low Flow.

Authors:  Patrick A Murphy; Noor Jailkhani; Sarah-Anne Nicholas; Amanda M Del Rosario; Jeremy L Balsbaugh; Shahinoor Begum; Amy Kimble; Richard O Hynes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-19       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.